Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type <scp>II</scp> Diabetes Mellitus

Authors

Institutions

Publication Details

Journal
Pharmacoepidemiology and Drug Safety
Published
2025-12-01
DOI
https://doi.org/10.1002/pds.70277
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus

Oluwasola Abayomi Adelusi, Olalekan Onisuru, Ikechukwu Achilonu, Chinyere Aloke et al.
1 citations
Pharmacoepidemiology and Drug Safety
Diabetes Treatment and Management
1.29
article

Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus

Oluwasola Abayomi Adelusi, Olalekan Onisuru, Ikechukwu Achilonu, Chinyere Aloke, Iwuchukwu A. Emmanuel
article en
1 citations

Abstract

No abstract available for this paper.
Pharmacoepidemiology and Drug SafetyVol. 34(12)
Funai Electric (Japan) (JP), University of the Witwatersrand (ZA), University of Johannesburg (ZA)
Openalex Percentile: Top 13%
Diabetes Treatment and Management
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.